Refractory Primary Mediastinal Large B-Cell Cell Lymphoma
1 clinical trials · Condition
◉ Watch Refractory Primary Mediastinal Large B-Cell Cell Lymphoma
| Record | Firm | Date |
|---|---|---|
| Treatment by a Bispecific CD3xCD20 Antibody for Relapse/Refractory Lymphomas After CAR T-cells Therapy (NCT04703686) | The Lymphoma Academic Research Organisation | 2021-03-30 |
Track Refractory Primary Mediastinal Large B-Cell Cell Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.